Comment on: Perceptions of bariatric surgery in patients with type 2 diabetes: data from a self-administered questionnaire

In 1991, the National Institutes of Health (NIH) convened a consensus development conference to establish the criteria and surgical treatment for patients with severe obesity [ 1 Eisenberg D. Shikora S.A. Aarts E. Aminian A. et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): indications for metabolic and bariatric surgery. Surg Obes Relat Dis. 2022; 18: 1345-1356 Abstract Full Text Full Text PDF PubMed Scopus (199) Google Scholar ]. Integral to the consensus statement is the association of obesity with chronic medical conditions, including type 2 diabetes (T2D) [ 2 Haskins I.N. Corcelles R. Froylich D. et al. Primary inadequate weight loss after Roux-en-Y gastric bypass is not associated with poor cardiovascular or metabolic outcomes: experience from a single institution. Obes Surg. 2017; 27: 676-680 Crossref PubMed Scopus (10) Google Scholar ]. In fact, some studies report that up to 80% of patients with T2D also have obesity [ 3 Mugharbel K.M. Al-Mansouri M.A. Prevalence of obesity among type 2 diabetic patients in Al-khobar primary health care centers. J Family Community Med. 2003; 10: 49-53 Crossref PubMed Google Scholar ]. In addition to T2D, obesity has been found to be associated with many other chronic medical conditions, including cardiovascular disease, musculoskeletal disease, and even some cancers. Because of the growing literature showing an association between obesity and cardiometabolic diseases as well as the improvement in cardiometabolic markers following bariatric surgery, bariatric surgery is now often referred to as "metabolic surgery." [ 4 Cordera R. Adami G.F. From bariatric to metabolic surgery: looking for a "disease modifier" surgery for type 2 diabetes. World J Diabetes. 2016; 7: 27-33 Crossref PubMed Google Scholar ] Perceptions of bariatric surgery in patients with type 2 diabetes: data from a self-administered questionnaireSurgery for Obesity and Related DiseasesVol. 19Issue 12PreviewAlthough bariatric surgery (BS) is recommended for patients with type 2 diabetes (T2D) and moderate to severe obesity, only approximately 2% of patients undergo surgery. Full-Text PDF Comment on: Impact of prior bariatric surgery on outcomes of hospitalized patients with systemic lupus erythematosus: a propensity score-matched analysis of the U.S. Nationwide Inpatient SampleSurgery for Obesity and Related DiseasesPreviewThe myriad of benefits from metabolic and bariatric surgery (MBS) include long-term mitigation of obesity-associated medical comorbidities, improved quality of life, and increased life expectancy. The 1991 NIH consensus development conference panel published MBS patient selection guidelines over 30 years ago with limited studies and general clinical knowledge about obesity-related health issues. Since the 1980s, there has been an explosion in research studies looking at the positive impact of MBS on obesity-related medical problems. Full-Text PDF